Kim, K. W., Kim, D., Park, H., Kang, D., Ahn, J., Wong, A. Y. T., . . . Park, D. Rationale and design of the ADAPT-TAVR trial: A randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement. BMJ Publishing Group.
Chicago Style (17th ed.) CitationKim, Kyung Won, et al. Rationale and Design of the ADAPT-TAVR Trial: A Randomised Comparison of Edoxaban and Dual Antiplatelet Therapy for Prevention of Leaflet Thrombosis and Cerebral Embolisation After Transcatheter Aortic Valve Replacement. BMJ Publishing Group.
MLA (9th ed.) CitationKim, Kyung Won, et al. Rationale and Design of the ADAPT-TAVR Trial: A Randomised Comparison of Edoxaban and Dual Antiplatelet Therapy for Prevention of Leaflet Thrombosis and Cerebral Embolisation After Transcatheter Aortic Valve Replacement. BMJ Publishing Group.